Revilleza, Isabelita C.
HRN: 28-18-27 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/22/2025
AZITHROMYCIN 500MG TABLET (TAB)
12/22/2025
03/22/2026
PO
500mg
3x/week MWF
HIV Prophylaxis
Checking Final Appropriateness
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes